Nstemi - non-ST segment elevation myocardial infarction (MI)

Clinical trials for Nstemi - non-ST segment elevation myocardial infarction (MI) explained in plain language.

Never miss a new study

Get alerted when new Nstemi - non-ST segment elevation myocardial infarction (MI) trials appear

Sign up with your email to follow new studies for Nstemi - non-ST segment elevation myocardial infarction (MI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1 Completed 1

Heart attack patients get early cholesterol drug in landmark trial

Disease control Not yet recruiting

This study tests whether giving a powerful cholesterol-lowering drug (recaticimab) early after a heart attack can safely reduce future heart problems. About 2,442 adults who recently had a heart attack will receive the drug or standard care. The goal is to see if this approach lo…

Matched conditions: NSTEMI - NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION (MI)

Phase 4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC

Nstemi - non-ST segment elevation myocardial infarction (MI)

Get alerted when new Nstemi - non-ST segment elevation myocardial infarction (MI) trials appear

Heart attack patients get early cholesterol drug in landmark trial